S&P 500   4,981.80
DOW   38,612.24
QQQ   425.61
Palo Alto Networks, Keysight fall; Garmin, Toll Brothers rise, Wednesday, 2/21/2024
Is Gold Really Boring? (Ad)
Palo Alto Networks aims at cyber security leadership
3 Reasons the Capital One-Discover merger is a big deal
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
How major US stock indexes fared Wednesday, 2/21/2024
Germany says Europe's largest economy is in 'troubled waters' and cuts its growth forecast
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
Teladoc Health gaps down to support level after weak guidance
Housing data weakens, but Toll Brothers stock is still a buy
S&P 500   4,981.80
DOW   38,612.24
QQQ   425.61
Palo Alto Networks, Keysight fall; Garmin, Toll Brothers rise, Wednesday, 2/21/2024
Is Gold Really Boring? (Ad)
Palo Alto Networks aims at cyber security leadership
3 Reasons the Capital One-Discover merger is a big deal
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
How major US stock indexes fared Wednesday, 2/21/2024
Germany says Europe's largest economy is in 'troubled waters' and cuts its growth forecast
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
Teladoc Health gaps down to support level after weak guidance
Housing data weakens, but Toll Brothers stock is still a buy
S&P 500   4,981.80
DOW   38,612.24
QQQ   425.61
Palo Alto Networks, Keysight fall; Garmin, Toll Brothers rise, Wednesday, 2/21/2024
Is Gold Really Boring? (Ad)
Palo Alto Networks aims at cyber security leadership
3 Reasons the Capital One-Discover merger is a big deal
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
How major US stock indexes fared Wednesday, 2/21/2024
Germany says Europe's largest economy is in 'troubled waters' and cuts its growth forecast
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
Teladoc Health gaps down to support level after weak guidance
Housing data weakens, but Toll Brothers stock is still a buy
S&P 500   4,981.80
DOW   38,612.24
QQQ   425.61
Palo Alto Networks, Keysight fall; Garmin, Toll Brothers rise, Wednesday, 2/21/2024
Is Gold Really Boring? (Ad)
Palo Alto Networks aims at cyber security leadership
3 Reasons the Capital One-Discover merger is a big deal
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
How major US stock indexes fared Wednesday, 2/21/2024
Germany says Europe's largest economy is in 'troubled waters' and cuts its growth forecast
Gold Could Be Heading for Record Highs - But How to Play It? (Ad)
Teladoc Health gaps down to support level after weak guidance
Housing data weakens, but Toll Brothers stock is still a buy

Vaxxinity (VAXX) Earnings Date, Estimates & Call Transcripts

$0.67
+0.03 (+4.67%)
(As of 02/21/2024 ET)
Skip Charts & View Estimated and Actual Earnings Data

VAXX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

VAXX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Vaxxinity Analyst EPS Estimates

Current Year EPS Consensus Estimate:($0.51) EPS
Next Year EPS Consensus Estimate: ($0.42) EPS

VAXX Earnings Date and Information

Vaxxinity has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 25th, 2024 based off prior year's report dates.

Vaxxinity Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
3/25/2024
Estimated)
------- 
11/8/2023Q3 2023($0.14)($0.10)+$0.04($0.10)--
8/9/2023Q2 2023($0.16)($0.11)+$0.05($0.11)--
5/9/2023Q1 2023($0.16)($0.15)+$0.01($0.15)--
3/27/2023Q4 2022($0.16)($0.16)-($0.16)--
11/10/2022Q3 2022($0.16)($0.15)+$0.01($0.15)--
8/11/2022Q2 2022($0.38)($0.14)+$0.24($0.14)--
5/9/2022Q1 2022($0.34)($0.31)+$0.03($0.15)-$0.02 million
3/24/2022Q4 2021($0.35)($0.48)($0.13)($0.48)--
12/22/2021Q3 2021($0.12)($0.24)($0.12)($0.44)-$0.05 million












Vaxxinity Earnings - Frequently Asked Questions

When is Vaxxinity's earnings date?

Vaxxinity has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 25th, 2024 based off last year's report dates. Learn more on VAXX's earnings history.

How much revenue does Vaxxinity generate each year?

Vaxxinity (NASDAQ:VAXX) has a recorded annual revenue of $70,000.00.

How much profit does Vaxxinity generate each year?

Vaxxinity (NASDAQ:VAXX) has a recorded net income of -$75.22 million. VAXX has generated -$0.52 earnings per share over the last four quarters.

What is Vaxxinity's EPS forecast for next year?

Vaxxinity's earnings are expected to grow from ($0.51) per share to ($0.42) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:VAXX) was last updated on 2/22/2024 by MarketBeat.com Staff